The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
SDHA Immunohistochemistry Detects Germline SDHA Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas
Abstract
Context: Pheochromocytoma-paraganglioma syndrome is caused by mutations in SDHB, SDHC, and SDHD, encoding subunits of succinate dehydrogenase (SDH), and in SDHAF2, required for flavination of SDHA. A recent report described a patient with an abdominal paraganglioma, immunohistochemically negative for SDHA, and identified a causal germline mutation in SDHA. Objective: In this study, we evaluated the significance of SDHA immunohistochemistry in the identification of new patients with SDHA mutations. Setting: This study was performed in the Erasmus Medical Center in Rotterdam (The Netherlands) and the Université Paris Descartes in Paris (France). Methods: We investigated 316 pheochromocytomas and paragangliomas for SDHA expression. Sequence analysis of SDHA was performed on all tumors that were immunohistochemically negative for SDHA and on a subset of tumors immunohistochemically positive for SDHA. Results: Six tumors were immunohistochemically negative for SDHA. Four tumors from Dutch patients showed a germline c.91C→T SDHA gene mutation (p.Arg31X). Another tumor (from France) carried a germline SDHA missense mutation c.1753C→T (p.Arg585Trp). Loss of the wild-type SDHA allele was confirmed by loss of heterozygosity analysis. Sequence analysis of 35 SDHA immunohistochemically positive tumors did not reveal additional SDHA mutations. Conclusions: Our results demonstrate that SDHA immunohistochemistry on paraffin-embedded tumors can reveal the presence of SDHA germline mutations and allowed the identification of SDHA-related tumors in at least 3% of patients affected by apparently sporadic (para)sympathetic paragangliomas and pheochromocytomas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Germline SDH mutations have been identified in the SDH subunits SDHA–SDHD and also in SDH assembly factor 2 in tumor predisposition syndromes (Hao et al., 2009; Korpershoek et al., 2011; Neumann et al., 2004; Niemann and Müller, 2000; Oudijk et al., 2013; Pollard et al., 2005; Ricketts et al., 2008; Ricketts et al., 2010).”
From SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways (2013) · cites this paper as Korpershoek et al., 2011
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Lenders, J. W. M., Eisenhofer, G., Mannelli, M., & Pacák, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,541
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730
SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
Hao, H.-X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.-P., Kunst, H., Devilee, P., Cremers, C. W. R. J., Schiffman, J. D., Bentz, B. G., et al. (2009) · Science · doi:10.1126/science.1175689 · Cited by 702
Self-citationSDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaı̂tre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 645
Self-citationvan Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F. B. M., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 554
Self-citationSDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
Bayley, J., Kunst, H. P. M., Cascón, A., Sampietro, M. L., Gaal, J., Korpershoek, E., Hinojar‐Gutiérrez, A., Timmers, H. J. L. M., Hoefsloot, L. H., Hermsen, M. A. J. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70007-3 · Cited by 283
Self-citationSuccinate dehydrogenase and fumarate reductase from Escherichia coli
Cecchini, G., Schröder, I., Gunsalus, R. P., & Maklashina, E. (2002) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(01)00238-9 · Cited by 279
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–277 of 277
Recent developments in eosinophilic renal neoplasms: what's new, true and important?
Trpkov, K., Siadat, F., & Saleeb, R. (2025) · Histopathology · doi:10.1111/his.70001 · Cited by 6
Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma
Lalloo, F. I. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-29998-3_7 · Cited by 6
Renal Cell Tumors: Molecular Findings Reshaping Clinico-pathological Practice
Tretiakova, M. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.08.003 · Cited by 6
SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
Branzoli, F., Salgues, B., Marjańska, M., Laloi-Michelin, M., Herman, P., Collen, L. L., Delemer, B., Mallart-Riancho, J., Kuhn, E., Jublanc, C., et al. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0198 · Cited by 6
Self-citationFamilial endocrine tumours: pheochromocytomas and extra-adrenal paragangliomas – an update
Korpershoek, E., van Nederveen, F. H., Komminoth, P., & de Krijger, R. R. (2017) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2017.06.001 · Cited by 7
Self-citationHistopathology of Parasellar Neoplasms
Manojlović-Gačić, E., Rostami, E., Karavitaki, N., & Casar‐Borota, O. (2020) · Neuroendocrinology · doi:10.1159/000507084 · Cited by 6
Role of SDHAF2 and SDHD in von Hippel–Lindau Associated Pheochromocytomas
Kugelberg, J., Welander, J., Schiavi, F., Fassina, A., Bäckdahl, M., Larsson, C., Opocher, G., Söderkvist, P., Dahia, P. L. M., Neumann, H. P. H., et al. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2373-2 · Cited by 6
Heritable and Syndromic Pheochromocytoma and Paraganglioma
Kopp, P. A. (2018) · Contemporary Endocrinology · doi:10.1007/978-3-319-77048-2_4 · Cited by 5
First-positive surveillance screening in an asymptomatic SDHA germline mutation carrier
White, G., Tufton, N., & Akker, S. A. (2019) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-19-0005 · Cited by 5
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance
Leo, A. D., Ruscelli, M., Maloberti, T., Coluccelli, S., Repaci, A., de Biase, D., & Tallini, G. (2023) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-023-03713-4 · Cited by 5
A Pathologist’s View: Molecular Profiles for Diagnosing Pheochromocytomas and Paragangliomas
Kimura, N. (2015) · International Journal of Endocrine Oncology · doi:10.2217/ije.15.16 · Cited by 5
Neuroendocrine Neoplasms, Olfactory Neuroblastomas and Paragangliomas of the Head and Neck
Klöppel, G., Franchi, A., & Matías‐Guiu, X. (2016) · Springer eBooks · doi:10.1007/978-3-662-49672-5_11 · Cited by 5
Outcomes of Carotid Body Tumor Management with Active Surveillance
Lyle, D. A., Lopez, A., Osofsky, R. B., Wiemann, B. Z., Boyd, N. H., Olson, G. T., & Rana, M. A. (2022) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894221105833 · Cited by 5
Données récentes sur l’hypertension endocrine
Al‐Salameh, A., Cohen, R., Chanson, P., & Plouin, P. (2012) · Annales d Endocrinologie · doi:10.1016/s0003-4266(12)70012-4 · Cited by 4
Self-citationSturrock, B. R., Macnamara, E. F., McGuire, P. J., Kruk, S., Yang, I., Murphy, J. L., Undiagnosed Diseases Network, Tifft, C., & Gordon‐Lipkin, E. M. (2021) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1692 · Cited by 4
Syndromes that link the endocrine system and genitourinary tract
Özlük, Y., & Kiliçaslan, İ. (2015) · Turkish Journal of Pathology · doi:10.5146/tjpath.2015.01322 · Cited by 4
Hereditary Neuroendocrine Tumor Syndromes
Faggiano, A., Ramundo, V., Circelli, L., & Colao, A. (2013) · InTech eBooks · doi:10.5772/53841 · Cited by 4
Implications of SDHB genetic testing in patients with sporadic pheochromocytoma
Maignan, A., Guérin, C., Julliard, V., Paladino, N. C., Kim, E., Roche, P., Castinetti, F., Essamet, W., Mancini, J., Impériale, A., et al. (2017) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-017-1564-y · Cited by 4
Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma
Bahougne, T., Impériale, A., Avérous, G., Chabrier, G., Burnichon, N., Gimenez‐Roqueplo, A., Dali‐Youcef, N., Libé, R., Baudin, É., Roy, C., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0431 · Cited by 3
Self-citationNeue WHO-Klassifikation 2022: Harnblasenkarzinom
Gaisa, N. T., Hartmann, A., & Knüchel‐Clarke, R. (2023) · Die Pathologie · doi:10.1007/s00292-023-01183-8 · Cited by 3
Shi, C., Liu, J., Zeng, Z.-P., Miao, Q., Fang, L., Chen, S., Ping, F., Sun, H., Lü, L., Chen, L., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad093 · Cited by 3
Paraganglioma of the tongue with SDHB gene mutation in a patient with Graves’ disease
Álvarez, M. A. D., Rodríguez, J. J. T., & Robledo, M. (2019) · Clinical Case Reports · doi:10.1002/ccr3.2065 · Cited by 3
Somatic SDHA mutations in paragangliomas in siblings
Huang, Y.-C., Chang, H., Chen, M., Huang, K., Li, A. F., Lin, C., Shyr, Y., & Fang, W. (2020) · Medicine · doi:10.1097/md.0000000000022497 · Cited by 3
Feocromocitoma-Paraganglioma: revisión de tema
Román-Gonzaléz, A., Sierra-Zuluaga, J., Gutiérrez-Restrepo, J., Barrera, C. A. B., & Vásquez, C. J. (2015) · Medicina y Laboratorio · doi:10.36384/01232576.115 · Cited by 3
A case of Carney triad complicated by renal cell carcinoma and a germline SDHA pathogenic variant
Wurth, R., Jha, A., Kamilaris, C. D. C., Gill, A. J., Poplawski, N. K., Xekouki, P., Quezado, M., Pacák, K., Stratakis, C. A., & Hannah‐Shmouni, F. (2021) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-20-0170 · Cited by 3
Pheochromocytoma and Paraganglioma
Robledo, M., Currás, M., & Cascón, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-74448-9_5 · Cited by 3
Consultation génétique des phéochromocytomes et paragangliomes
Cardot-Bauters, C., Ainaouï, M., Coppin, L., & Pigny, P. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2013.07.032 · Cited by 2
Rueda-Galvis, M. V., Román-Gonzaléz, A., & Agredo-Delgado, V. (2022) · IATREIA · doi:10.17533/udea.iatreia.187 · Cited by 2
Molecular uropathology: what a practising pathologist should know
Bahlinger, V., Lange, F., & Eckstein, M. (2024) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2024.02.003 · Cited by 3
Mitochondrial Respiratory Chain Complex II
Ganesh, J., Wong, L. C., & Gorman, E. B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3722-2_13 · Cited by 2
Apport du pathologiste dans les prédispositions héréditaires aux paragangliomes et phéochromocytomes
Broudin, C., Favier, J., Verkarre, V., & Méatchi, T. (2020) · Annales de Pathologie · doi:10.1016/j.annpat.2020.01.010 · Cited by 2
Self-citationPathology of Pheochromocytoma and Paraganglioma
Turchini, J., Gill, A. J., & Tischler, A. S. (2018) · Contemporary Endocrinology · doi:10.1007/978-3-319-77048-2_2 · Cited by 2
Yue, X., Liu, B., Han, T., Luo, N., Lu, G., Guo, D., Bu, F., & Wang, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.835220 · Cited by 2
Genetic Alterations in Pheochromocytoma and Paraganglioma
Welander, J. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-114806 · Cited by 2
Paragangliomas of the head and neck region
Pindicura, K., Priyadarshini, A. R., Dandala, S. R., Rajarikam, N., & Namala, V. (2017) · Journal of Dr. YSR University of Health Sciences. · doi:10.4103/jdrntruhs.jdrntruhs_5_17 · Cited by 2
Carney-Stratakis Syndrome presenting as occult mediastinal paraganglioma
Bailey, R. E., Sharma, A., & Parent, E. E. (2020) · Radiology Case Reports · doi:10.1016/j.radcr.2020.06.029 · Cited by 2
A Case for Genetic Testing in Isolated Tympanic Paragangliomas
Shrivastava, M. K., Curran, J. F., Sheerin, F., Mohammadi, B. J., Halliday, D. J., & MacKeith, S. A. C. (2022) · Otology & Neurotology · doi:10.1097/mao.0000000000003557 · Cited by 1
Garrido-Moraga, R., Serrano‐Lorenzo, P., Esteban-Amo, M. J., Bellusci, M., de la Fuente, M. Á., Arenas, J., González-Quintana, A., Ugalde, C., Simarro, M., & Martín, M. A. (2026) · Mitochondrion · doi:10.1016/j.mito.2026.102149 · Cited by 1
Genetic Testing After Previous BRCA Testing: A Case Study
Ward, M. (2016) · Clinical journal of oncology nursing · doi:10.1188/16.cjon.660-663 · Cited by 1
Soft-Tissue Tumors of the Head and Neck
Folpe, A. L., & Bishop, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-53114-6.00009-2 · Cited by 1
Bilateral Pheochromocytoma with Germline MAX Variant without Family History
Hata, S., Asano, M., Tominaga, H., Hamaguchi, M., Hongo, F., Usui, T., Konishi, E., & Fukui, M. (2022) · Clinics and Practice · doi:10.3390/clinpract12030035 · Cited by 1
Exome sequencing and SDH (A, B) immunohistochemistry of canine Pheochromocytomas
Abed, F. M., & Dark, M. J. (2022) · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences · doi:10.33899/ijvs.2022.135825.2526 · Cited by 2
Gupta, S., & Erickson, L. A. (2023) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2026.06.010 · Cited by 1
Genetics of Pheochromocytoma and Paraganglioma
Babic, B., & Nilubol, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_5 · Cited by 1
Genetic aspects of primary hyperaldosteronism and pheochromocytoma
Ворохобина, Н. В., Борисович, Ш. С., Александровна, Б. К., & Камильевна, Г. Р. (2017) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2017-23-3-178-185 · Cited by 1
SDHB mutated paraganglioma imitating thyroid tumor: A case report and review of literature
Maskoliūnaitė, V., Makūnaitė, G., Garnelytė, A., Abraitienė, A., & Beiša, V. (2018) · Case Reports in Clinical Pathology · doi:10.5430/crcp.v5n2p5 · Cited by 1
Paragangliomas and Pheochromocytomas
Mete, Ö., Tischler, A. S., & Asa, S. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-54391-4_12 · Cited by 1
Pheochromocytomas, Paragangliomas, and Pituitary Adenomas (3PAs) and Succinate Dehydrogenase Defects
Demidowich, A. P., & Stratakis, C. A. (2021) · Endocrinology · doi:10.1007/978-3-319-89497-3_13 · Cited by 1
Mutations de gènes impliqués dans le métabolisme énergétique et cancer
Thibault, C., & Gimenez‐Roqueplo, A. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2320-8
Self-citationSDH assembly in S. cerevisiae: focus on the functional role of SDH6
Meloni, F. (2012) · DSpaceUnipr (University of Parma)
La génétique des paragangliomes
Burnichon, N., Abermil, N., Buffet, A., Favier, J., & Gimenez‐Roqueplo, A. (2012) · Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale · doi:10.1016/j.aforl.2012.07.425
Self-citationGenetic and molecular background of pheochromocytoma and paraganglioma
Stenman, A. (2015) · Figshare
Hereditary Paraganglioma and Pheochromocytoma
Li, F., & Wong, L. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-19674-9_30
Molecular Genetics of Pheochromocytoma and Paraganglioma
Robledo, M., Currás-Freixes, M., & Cascón, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_2
Paragangliomas carotídeos: hacia un tratamiento personalizado que reduzca la morbilidad
Fernández‐Álvarez, V., Fernández, J. A., & Nieto, C. S. (2017) · Angiología · doi:10.1016/j.angio.2017.02.005
Pheochromocytomas and Paragangliomas: Genetics and Pathophysiology
Fishbein, L. M. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_8
Familial Head and Neck Paraganglioma and Genetic Testing
O’Connell, B. P., & Wanna, G. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-60955-3_15
The Role of TMEM127 in mTOR Pathway and Cancer Suppression
Wang, Q., & Wang, K. (2019) · International Journal of Sciences · doi:10.18483/ijsci.1985
Pheochromocytomas, Paragangliomas, and Pituitary Adenomas (3PAs) and Succinate Dehydrogenase Defects
Demidowich, A. P., & Stratakis, C. A. (2019) · Endocrinology · doi:10.1007/978-3-319-73082-0_13-1
Aim, L. B., Pigny, P., Castro‐Vega, L. J., Buffet, A., Amar, L., Bertherat, J. Y., Drui, D., Guilhem, I., Baudin, É., Lussey‐Lepoutre, C., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.8.12
Self-citationSuccinate Dehydrogenase Mutation and Paraganglioma Syndromes: A Review Article
Ramakant, P. (2021) · Indian Journal of Endocrine Surgery and Research · doi:10.5005/jp-journals-10088-11162
Pheochromocytoma/Paraganglioma
Nosé, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52480-3.50090-1
Beninato, T. M., & Duh, Q. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_30
dos Santos, A. B., Kowalski, L. P., Köhler, H. F., Goldenberg, D. C., Toledo, R. N., & de Carvalho, A. Y. (2022) · Springer eBooks · doi:10.1007/978-3-030-97687-3_1
Pheochromocytoma/Paraganglioma
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37678-5.50157-2
Miettinen, M. (2016) · Cambridge University Press eBooks · doi:10.1017/9781107707504.027
Pheochromocytoma and Adrenal Medullary Hyperplasia
(2024) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477473-08
Familial and Syndrome-Related Pheochromocytoma and Paraganglioma
(2024) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477473-10
Case report of a succinate dehydrogenase-deficient renal cell carcinoma
Turner, H., Theodosiou, M., Crawford, E., Jain, M., Macdougall, K., & Brockmoeller, S. F. (2025) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2025.10.002
Current Understanding of Carotid Body Paraganglioma Management
Kim, Y.-W. (2025) · Vascular Specialist International · doi:10.5758/vsi.250063
Pheochromocytoma & Paraganglioma
(2013) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2013.ahpaa.11
Molecular Pathology of Endocrine Gland Tumors
Paola, F. J. D., Calafato, G., Rhoden, K. J., & Tallini, G. (2026) · Surgical pathology clinics · doi:10.1016/j.path.2026.01.004
Impact des mutations SDH sur la réponse antitumorale et identification de nouveaux biomarqueurs
Lamy, C. (2021) · theses.fr (ABES) · doi:10.70675/036f6787z50daz43e6zbeafzbcebfb700048
Role of genomic testing in modern diagnostic surgical pathology practice
Dorwal, P., Cheah, A. L., Khani, A., Galea, L. A., Satgunaseelan, L., Kim, D., Moghimi, A., Pan, Z., Karunamurthy, A. D., Tan, I. K., et al. (2026) · Pathology · doi:10.1016/j.pathol.2026.08.014
Charting the Genetic Landscape and Clonal Architectures of Pheochromocytoma
Crona, J. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Metadata
- Authors
- Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.-P., van Dooren, M. F., de Herder, W. W., Tissier, F., Plouin, P.-F., van Nederveen, F. H., Dinjens, W. N. M., Gimenez-Roqueplo, A.-P., & de Krijger, R. R.
- Affiliations
- Erasmus MC (NL)
- Centre National de la Recherche Scientifique (FR)
- Department of Pathology (E.K., J.G., B.v.G., L.O., F.H.v.N., W.N.M.D., R.R.d.K.), Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- Département de Génétique (N.B., A.V., A.-P.G.-R.), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, 75015 Paris, France
- Leiden University Medical Center (NL)
- Josephine Nefkens Institute, and Departments of Clinical Genetics (M.F.v.D.), Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- Endocrinology (W.W.d.H.), Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- Institut National de la Santé et de la Recherche Médicale (INSERM), Unité (U)970, Paris Cardiovascular Research Center-PARC (J.F., N.B., N.G., A.-P.G.-R.), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, 75015 Paris, France
- Corresponding author
- Korpershoek, Esther
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-09-01
- Volume
- 96
- Issue
- 9
- Pages
- E1472-E1476
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2019411591
- Cited by
- 277
- References
- 17
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 19 · 2021: 14 · 2020: 18 · 2019: 20 · 2018: 26 · 2017: 32 · 2016: 17 · 2015: 22 · 2014: 26 · 2013: 29 · 2012: 31
- FWCI
- 29.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Universiteit Leiden
- Radboud Universiteit
- Erasmus Medisch Centrum
- Leids Universitair Medisch Centrum
- Radboud Universitair Medisch Centrum
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- SDHA, germline mutations, pheochromocytoma, paraganglioma, succinate dehydrogenase, loss of heterozygosity, sporadic cancer
- MeSH terms
- Adrenal Gland Neoplasms, Alleles, DNA Mutational Analysis, Humans, Immunohistochemistry, Paraganglioma, Pheochromocytoma, Germ-Line Mutation, Loss of Heterozygosity, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review